These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 14552653)

  • 1. The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression.
    Fava M
    J Clin Psychiatry; 2003; 64 Suppl 13():26-9. PubMed ID: 14552653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common pathways of depression and pain.
    Delgado PL
    J Clin Psychiatry; 2004; 65 Suppl 12():16-9. PubMed ID: 15315473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does depression hurt?
    Stahl SM
    J Clin Psychiatry; 2002 Apr; 63(4):273-4. PubMed ID: 12000200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of duloxetine on painful physical symptoms associated with depression.
    Goldstein DJ; Lu Y; Detke MJ; Hudson J; Iyengar S; Demitrack MA
    Psychosomatics; 2004; 45(1):17-28. PubMed ID: 14709757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical symptoms comorbid with depression and the new antidepressant duloxetine.
    Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2003 Dec; 41(12):13-8. PubMed ID: 14682027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine dysfunction and the pathophysiology and treatment of depression.
    Charney DS
    J Clin Psychiatry; 1998; 59 Suppl 14():11-4. PubMed ID: 9818625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noradrenergic versus serotonergic antidepressants: predictors of treatment response.
    Schatzberg AF
    J Clin Psychiatry; 1998; 59 Suppl 14():15-8. PubMed ID: 9818626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effectiveness of reboxetine versus fluoxetine in patients with atypical depression: a single-blind, randomized clinical trial.
    Taner E; Demir EY; Cosar B
    Adv Ther; 2006; 23(6):974-87. PubMed ID: 17276965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.
    Schatzberg AF
    J Clin Psychiatry; 2003; 64 Suppl 13():30-7. PubMed ID: 14552654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of norepinephrine in depression.
    Delgado PL; Moreno FA
    J Clin Psychiatry; 2000; 61 Suppl 1():5-12. PubMed ID: 10703757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation strategies with serotonergic-noradrenergic combinations.
    Nelson JC
    J Clin Psychiatry; 1998; 59 Suppl 5():65-8; discussion 69. PubMed ID: 9635550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norepinephrine involvement in antidepressant action.
    Frazer A
    J Clin Psychiatry; 2000; 61 Suppl 10():25-30. PubMed ID: 10910014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for a pure noradrenergic drug in the treatment of depression?
    Montgomery SA
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S3-9; discussion S71-3. PubMed ID: 9169305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based treatment paradigms for depressed patients with pain and physical symptoms.
    Fishbain DA
    J Clin Psychiatry; 2009 Jul; 70(7):e22. PubMed ID: 19653968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The psychopharmacology of painful physical symptoms in depression.
    Stahl SM
    J Clin Psychiatry; 2002 May; 63(5):382-3. PubMed ID: 12019660
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of norepinephrine in the treatment of depression.
    J Clin Psychiatry; 1999 Sep; 60(9):623-31. PubMed ID: 10520985
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine.
    Trivedi MH; Desaiah D; Ossanna MJ; Pritchett YL; Brannan SK; Detke MJ
    Int Clin Psychopharmacol; 2008 May; 23(3):161-9. PubMed ID: 18408530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder.
    Aragona M; Bancheri L; Perinelli D; Tarsitani L; Pizzimenti A; Conte A; Inghilleri M
    Eur J Pain; 2005 Feb; 9(1):33-8. PubMed ID: 15629872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
    Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
    Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning.
    Dubini A; Bosc M; Polin V
    J Psychopharmacol; 1997; 11(4 Suppl):S17-23. PubMed ID: 9438229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.